I don't know. Why are they seeking a licence for the tablets rather than the more effective injections?

I've asked the question openly on the BartsMS Blog about the potential switch from injectable to tablet. I would expect this introduces a huge departure from the previous trial and research data with the injectable. Does it absorb into the system correctly, are there side effects not usually associated with the injectable form, is it as effective in tablet form, does stomach acid destroy the drug is that why it's always been injected ? The cynical part of me says the development of a table will simply mean 10mg of Clad in tablet form will be £500 - £1,000 per dose rather then £165 in injectable and will mean as a concept it takes a much increased time to approval and use.